Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism.

[1]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[2]  D. Geddes,et al.  Inhaled corticosteroids: benefits and risks. , 1992, Thorax.

[3]  J. G. Douglas,et al.  Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. , 1992, Thorax.

[4]  D. Morrison,et al.  Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease. , 1992, Thorax.

[5]  Partridge,et al.  International Consensus Report on Diagnosis and Treatment of Asthma. , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  J. Baskerville,et al.  Effects of dose and dosing schedule of inhaled budesonide on bone turnover. , 1991, The Journal of allergy and clinical immunology.

[7]  Toogood Jh,et al.  Effects of inhaled and oral corticosteroids on bone. , 1991 .

[8]  J. Aloia,et al.  Effect of inhaled corticosteroid on bone density in asthmatic patients: a pilot study. , 1991, Annals of allergy.

[9]  David W. Bates,et al.  CLINICAL USE OF BONE DENSITOMETRY , 1991 .

[10]  J. Baskerville,et al.  Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. , 1991, The Journal of clinical endocrinology and metabolism.

[11]  S. Capewell,et al.  Bone turnover during high dose inhaled corticosteroid treatment. , 1991, Thorax.

[12]  E. Juniper,et al.  Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. , 1990, The American review of respiratory disease.

[13]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis: pathogenesis and management. , 1990, Annals of internal medicine.

[14]  J. Toogood.  Complications of topical steroid therapy for asthma. , 1990, The American review of respiratory disease.

[15]  J. Baskerville,et al.  Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. , 1989, The Journal of allergy and clinical immunology.

[16]  Ahmed Ar,et al.  Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. , 1989 .

[17]  G. Wells,et al.  Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. , 1988, The American review of respiratory disease.

[18]  C. Salome,et al.  Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not. , 1987, The American review of respiratory disease.

[19]  P. Gallop,et al.  Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay. , 1985, Clinical chemistry.

[20]  L. Rosenhall,et al.  High Dose Inhaled Budesonide in the Treatment of Severe Steroid‐Dependent Asthmatics , 1985, Allergy.

[21]  M. Hodson,et al.  Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. , 1983, Thorax.

[22]  A. Adinoff,et al.  Steroid-induced fractures and bone loss in patients with asthma. , 1983, The New England journal of medicine.

[23]  M. Lebowitz,et al.  Changes in the normal maximal expiratory flow-volume curve with growth and aging. , 1983, The American review of respiratory disease.

[24]  N. Thomson,et al.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. , 1981, The Journal of allergy and clinical immunology.

[25]  D. Webb.  Steroids in allergic disease. , 1981, The Medical clinics of North America.

[26]  P. Lieberman,et al.  Complications of long-term steroid therapy for asthma. , 1972, The Journal of allergy and clinical immunology.

[27]  K. Maunsell,et al.  Long-term corticosteroid treatment of asthma. , 1968, British medical journal.

[28]  S. Udenfriend,et al.  A specific method for the analysis of hydroxyproline in tissues and urine. , 1960, Analytical biochemistry.